Nailed It. Now What?

If earnings hold up for the next two quarters, the market will go up on value expansion alone. Granted, that’s a big “if.” If earnings hold up for the next two quarters, the market will go up on value expansion alone. Granted, that’s a big “if.” [Energy and Capital logo] Nailed It. Now What? [Christian DeHaemer Photo] By [Christian DeHaemer]( Written Apr 26, 2022 About four months ago on December 7, 2021, I told you that the markets were heading lower and to sell the rips not buy the dips. This is what I wrote: This is the most ominous chart I’ve seen in years: [spx] This is a five-year, monthly candlestick chart of the SPX. The SPX is based on the 500 top companies in the United States. Each candlestick represents a month. The chart goes back to 2017. That red candlestick from two months ago (October) that looks like an upside down hammer is called a “gravestone doji.” How to Play the $30 Trillion ESG Trend ESG (environmental, social, and governance) investing is predicted to become as big as $30 TRILLION... And with climate change making the headlines every day, one tiny company could become an ESG darling. Early investors already made 1,172% within a few months... And as soon as a green ETF includes this firm in its portfolio, shares could soar much higher. Today, you can get in for less than $5. But with a radical new global climate policy unfolding, there’s not much time to act. [Click here for all the details.]( Japanese Rice Traders [Candlestick charts]( go back 1,000 years to rice traders in Japan. A green candlestick means the asset price closed higher than it opened. Red means the market closed lower than it opened. The thin line or tail represents the highs and lows during the session. Here is the gravestone doji diagram: [Doji] What this means is that the buyers took the market up at the start of the month but then the sellers overwhelmed them. It closed where it opened. It means that the buyers are done. There are no more buyers. This is also called a blowoff top. When this comes after a long bullish market where everything is overvalued, it is bad news. You’ll notice the last one in the first chart came in January of 2020 when COVID hit and the SPX sold off about 1,000 points. When I first started trading, a salty veteran referred to this as “flags planted on the top of a mountain,” like Hillary and Norgay on the peak of Everest. Sometimes a gravestone doji doesn't mean very much. The market consolidates and goes on. But there is a lot of air under this market. The market cap to GDP is the highest it has ever been. Inflation is running well above the Fed’s target rate of 2% and rate hikes are back on the menu. We are 12 years into this heated bull market. A 700 to 1,000 point drop on the S&P 500 could happen over the next few months. "Miracle Mineral" at Center of Multi-Trillion Wealth Bonanza Inside each of these spheres is a natural resource more important than oil, coal, or gas. It’s called the “Miracle Mineral.” [See how this little-known resource could give savvy investors the chance to turn $500 into $82,175 over the next few months.]( Nailed It I was correct in my call. The SPX sold off 762 points. That said, time waits for no man. Here is the market this week. [spx2] This is a six-month, daily chart of the S&P 500. As you can see, we are going down and retesting that double bottom at 4,200. That is a major support level. If you are a trader you would buy call options. I like the May 2022 4,290.00 SPX calls, which are trading at $31.05. If the market bounces and we make back half the sell off — which seems likely — you’d be in the money by next week. The #1 Strategy for Biotech Stocks? It’s no secret that biotech is the most exciting investment arena there is. There’s never a shortage of demand for new treatments for the world’s worst diseases, like cancer, Alzheimer’s, and arthritis. And with my new trading system, “Project Greenlight,” you’ll always know with up to 95% confidence which of those new medicines will be approved by the FDA and which won’t... This could set investors up to make six figures or more in biotech profits. And right now, there's a tiny biotech firm trading for pennies on the dollar with a medicine that’s on the brink of FDA approval... [Learn more about this unique opportunity today.]( After that I expect this market will be in a trading range until there is a discernible trend or valuations work themselves to a more reasonable number. The current P/E ratio is 21.35 on the S&P 500. The mean P/E ratio over its 150-year history is 15.97. The post-great financial crisis low in 2012 was around 14.80. If earnings hold up for the next two quarters, the market will go up on value expansion alone. Granted, that’s a big “if.” The upshot is that at this point there is no discernible trend, so as an investor it's difficult to make a move. If you are a trader, however, you can make a lot of money playing a range-bound market. My good friend Sean has a trading service called Naked Trades that does just that using options. [Give it a shot here.]( [Christian DeHaemer Signature] Christian DeHaemer [[follow basic]@TheDailyHammer on Twitter]( Since 1995, Christian DeHaemer has specialized in frontier market opportunities. He has traveled extensively and invested in places as varied as Cuba, Mongolia, and Kenya. Chris believes the best way to make money is to get there first with the most. Christian is the founder of [Bull and Bust Report]( and an editor at [Energy and Capital](. For more on Christian, see his editor's [page](. Browse Our Archives [Warning! Your City Is Being Watched]( [Tesla in the Vanguard]( [Why Elon Musk Is Unstoppable]( [To Those Who Listened and Bought Oil, You're Welcome]( [What Putin Knows]( --------------------------------------------------------------- This email was sent to {EMAIL}. It is not our intention to send email to anyone who doesn't want it. If you're not sure why you've received this e-letter, or no longer wish to receive it, you may [unsubscribe here]( and view our privacy policy and information on how to manage your subscription. To ensure that you receive future issues of Energy and Capital, please add newsletter@energyandcapital.com to your address book or whitelist within your spam settings. For customer service questions or issues, please contact us for assistance. Energy and Capital, Copyright © 2022, Angel Publishing LLC. All rights reserved. 3 E Read Street, Baltimore, MD 21202. Your privacy is important to us – we will never rent or sell your e-mail or personal information. Please read our [Privacy Policy](. Neither the publisher nor the editors are registered investment advisors. Subscribers should not view this publication as offering personalized legal or investment advice. Read our [Details and Disclosures.]( ---------------------------------------------------------------